Security for Healthtechs: how to shield sensitive clinical data in APIs, apps, and the cloud
Digital health startups grow fast and handle the most sensitive type of data there is — clinical records. Decripte structures application security, responds to incidents, and brings healthtechs into LGPD compliance without slowing product velocity.
Direct answer
To protect a healthtech, prioritize the three fronts that concentrate the real risk. First: object-level and function-level authorization in APIs — the flaw that most exposes patient records across users, classified by the OWASP API Security Top 10 as BOLA (Broken Object Level Authorization). Second: the handling of sensitive personal health data under the LGPD, which requires a specific legal basis, minimization, encryption, and an incident response plan with notification to the ANPD and to data subjects when there is relevant risk. Third: cloud and pipeline hardening — reviewed IaC, secrets management, and software supply chain. In practice this becomes application and API pentesting focused on broken authorization, continuous monitoring by a 24x7 SOC, vulnerability management prioritized by real exposure, and an SDLC with automated security tests. Decripte delivers this full package and maintains an incident containment SLA of up to 1 hour. Start with a free assessment at decripte.com.br/intelligence-center and, to sign up, go to decripte.io/start.
24/7
SOC monitoring healthcare APIs and apps
≤1h
Containment SLA for incident response
LGPD
Health data is sensitive personal data (art. 5, II)
OWASP
API Top 10 guides authorization testing
In summary
- ›The most common and most severe flaw in healthcare apps is broken authorization (BOLA/IDOR): a patient accesses another patient's clinical record just by changing an identifier in the API request.
- ›Under the LGPD, health data is sensitive personal data and requires a specific legal basis, minimization, encryption, and a response plan with notification to the ANPD and to data subjects when there is relevant risk or harm.
- ›Immature security in a startup is almost never a missing firewall — it is the absence of authorization tests in the SDLC, secrets committed to the repository, and misconfigured cloud buckets/datastores.
- ›Application and API pentesting finds the flaw before the attacker; a 24x7 SOC detects abuse in production; vulnerability management closes the window; compliance turns it all into an auditable process.
- ›Product velocity and security are not opposites: the path is to embed automated tests in the pipeline (DAST, SCA, secret scanning) so the pipeline catches the regression, not the customer.
Cibersegurança para Healthtechs
Digital health startups grow fast and handle the most sensitive type of data there is — clinical records. Decripte structures application security, responds to incidents, and brings healthtechs into LGPD compliance without slowing product velocity.
Why healthtechs are a priority target
In just a few months of operation, a healthtech concentrates exactly the ingredients an attacker looks for: extremely high-value data, an attack surface exposed by design, and security maturity still under construction. The product is an API and an app — telemedicine, electronic health records, scheduling, prescriptions, integrations with labs and health plans. Every endpoint that serves clinical data is a door. And the data behind those doors is not an email or a card number that can be swapped out: it is a person's diagnosis, exam, medication, and history. There is no possible rotation for a leaked medical history.
The mismatch is structural. The pressure to ship fast — closing the first contract with a health plan, hitting the user target, raising the next round — pushes the engineering team to prioritize functionality over control. Authorization becomes an if scattered across the code instead of a central layer. Production secrets go into the repository "just to make the deploy work." The database goes up in the cloud with a port left open "temporarily." Each of these shortcuts is rational in isolation and catastrophic in combination, because the data handled is sensitive and the regulator is specific.
What makes health data different
Under the LGPD, data relating to health is a category of sensitive personal data (art. 5, item II). This is not a semantic detail: it changes the required legal basis, raises the duty of care, restricts sharing, and turns a leak into a notification event to the ANPD and potentially to data subjects. Unlike a password, a leaked diagnosis is permanent and irreversible.
Add to that the ecosystem. A healthtech rarely operates alone: it integrates with clinics, labs, health plans, payment gateways, digital signature providers, and dozens of open source libraries. Each integration is a trust relationship that can be abused — what OWASP calls Server-Side Request Forgery and unsafe consumption of third-party APIs, and what the industry more broadly calls supply chain risk. The modern attacker does not breach the castle through the wall; they enter through the transitive dependency or through a partner's credential.
The flaw that most exposes patient records: broken authorization
If there is a single vulnerability that defines the risk for healthtechs, it is broken object-level authorization — BOLA (Broken Object Level Authorization), the number one item in the OWASP API Security Top 10, historically also called IDOR (Insecure Direct Object Reference). The mechanism is simple and therefore devastating: the API receives a request that references an object by an identifier — GET /api/v1/pacientes/10432/prontuario — and the application authenticates who is asking but forgets to verify whether that user is entitled to that specific object. Change 10432 to 10433 and the neighboring patient's history appears on the screen.
Why it escapes functional testing
The QA test passes because the legitimate user sees their own data — the feature works. The flaw only appears when someone tries to see someone else's data. QA tests the happy path; security tests the adversary's path. Without a specific test for cross-account authorization, broken authorization travels through the entire pipeline to production without triggering a single alarm.
The family is larger than BOLA. There is broken function-level authorization — BFLA (Broken Function Level Authorization) — in which an ordinary user accesses an administrative route that should be exclusive to an elevated profile, for example a bulk patient export endpoint or a prescription modification endpoint. There is broken authentication itself, with predictable tokens, sessions that do not expire, or exploitable password recovery flows. And there is excessive data exposure, when the API returns the entire patient object and the front end "hides" the sensitive fields on the client — where any traffic inspection reveals them.
Where authorization usually breaks in a healthtech
- ✓Endpoints that receive sequential or predictable IDs for patient, exam, appointment, or document.
- ✓Administrative routes (export, reports, user management) without server-side role verification.
- ✓GraphQL with resolvers that trust the client to filter what the user is allowed to see.
- ✓Integration webhooks and callbacks that accept requests without validating origin or scope.
- ✓JWT tokens with unverified authorization claims or with a signature accepted as 'none'.
- ✓Internal APIs exposed without authentication because 'only our front end calls them'.
The decisive technical point is architectural: authorization must be a centralized decision, made on the server, for each object and each action, against the request's authenticated identity — never delegated to the front end and never scattered as ad hoc checks in each controller. Where Decripte adds the most value is in finding these breaks before the attacker does, via targeted pentesting, and in helping the team consolidate authorization logic into a testable layer.
Is healthtechs data already exposed or up for sale? Find out now — for free.
Sem cartão, sem compromisso. Descubra em minutos o que já vazou da sua empresa e qual é o seu risco real.
Technical anatomy of the sector's five threats
Clinical data leaks via API and authorization flaws
A leak via API is the outcome of every broken authorization and every excessive data exposure. The root cause is almost never weak encryption — it is missing access control on the server. The sector-specific aggravating factor: the leaked data is sensitive and permanent, which turns a software bug into a data protection incident with regulatory obligations. The correct control combines object-level authorization, minimization of the API response (returning only what is needed), and an audit log of who accessed which record. The authorization flaw itself is number one in the OWASP API Top 10 precisely because it is hard to detect automatically — it requires understanding the business logic (who can see what) and therefore depends on qualified manual testing, not just a scanner.
Credential compromise
This includes secrets committed to the repository (API keys, database tokens, integration credentials), password reuse without MFA, and long-lived tokens that never expire. In a startup, the most common vector is the secret in the Git history — a key that leaked six months ago is still valid because no one rotated it. The control: secret scanning in the pipeline, a secrets vault, mandatory MFA, and rotation.
Supply chain
Open source dependencies with known vulnerabilities, malicious packages via typosquatting, and third-party integrations (labs, health plans, gateways) that expand the surface. The control is SCA (Software Composition Analysis) in the pipeline, a dependency inventory (SBOM), and input/output validation on every integration — treating every partner as untrusted by default.
Misconfigured cloud exposure
Object buckets with public listing, managed databases accessible from the internet, security groups with 0.0.0.0/0 on administration ports, IAM roles with overly broad permissions. It is a configuration error, not a code error — and it is what most frequently exposes an entire datastore all at once. The control is baseline hardening, IaC review, and continuous cloud posture scanning (CSPM).
The five threats are not independent: a compromised credential becomes a pivot to the misconfigured cloud, which exposes the datastore, whose improper access is enabled by the absence of authorization — and all of this enters through the supply chain dependency. That is why the defense must be layered and continuous, not a one-off pentest followed by six months of silence.
How Decripte finds the flaw: application and API pentesting
Decripte's pentest for healthtechs is not a vulnerability scan with a pretty report — it is adversarial testing conducted by specialists who think like the attacker and understand the business logic of the healthcare product. The central scope is authorization: we create multiple test users with distinct roles (patient, doctor, administrator, partner) and systematically try to access objects and functions outside each one's scope. That is how you find a BOLA before the real patient finds it.
What a healthtech pentest covers
- ✓Broken object-level authorization (BOLA/IDOR) across all endpoints that serve clinical data.
- ✓Broken function-level authorization (BFLA): access to administrative routes with an ordinary profile.
- ✓Authentication and session management: token strength, expiration, recovery flows, MFA.
- ✓Excessive data exposure in the API response and masking done only on the client.
- ✓Injection (SQL, NoSQL, commands), SSRF, and input validation in integrations.
- ✓Associated cloud configuration: secrets, IAM, datastore exposure.
- ✓Business logic abuse: manipulation of prescription, scheduling, and payment flows.
We follow recognized methodologies — OWASP Web Security Testing Guide, OWASP API Security Top 10, and OWASP MASVS for mobile apps — adapted to the healthcare regulatory context. Each finding comes with a reproducible proof of concept, severity calibrated by real business impact (a BOLA in patient records is critical, not medium), and remediation guidance that the engineering team can actually apply. The deliverable is not a list of CVEs: it is a map of what an attacker would do and how to close each path.
Continuous pentesting, not annual
A growing healthtech changes code every week. One pentest a year covers a snapshot of a product that no longer exists. Decripte works with recurring tests and post-fix retests, integrated into the release cadence, so that security keeps pace with the product's velocity instead of being a gate that opens once a year.
Detection and response: 24x7 SOC and vulnerability management
Finding the flaw in the pentest closes the known door. But in production, the attacker tries the door at any hour — and authorization abuse rarely triggers an error: the request is 'valid,' it is just accessing the wrong object. That is why Decripte's 24x7 SOC monitors behavioral patterns, not just signatures: sequential ID enumeration, spikes in record access by a single account, anomalous exports, authentications from unlikely locations, calls to administrative endpoints by profiles that should not touch them.
Telemetry that matters in a healthtech
Application and API logs (who accessed which object), authentication and MFA events, cloud logs (CloudTrail/equivalent), WAF events, and an audit trail of clinical data access. Without this telemetry, a leak via BOLA can go unnoticed for months — and the LGPD asks exactly when you knew and what you did.
Vulnerability management ties it all together: an inventory of what exists (assets, APIs, dependencies), prioritization by real exposure and exploitability — not by the raw CVSS number — and tracking the fix through to closure, with a retest. In a healthtech, this means distinguishing the thousands of scanner alerts from the handful of flaws that actually expose patient data, and ensuring those are closed within a timeframe consistent with the risk.
The vulnerability management cycle
- ✓Continuous discovery and inventory of assets, endpoints, and dependencies.
- ✓Assessment combining scanners (DAST/SAST/SCA) and manual criticality validation.
- ✓Prioritization by exposure, exploitability, and impact on sensitive data.
- ✓Remediation with deadlines by severity and support for the engineering team.
- ✓Retesting and verification that the fix actually closed the path.
- ✓Metrics on exposure time and trends for leadership and for audit.
What would an incident in healthtechs cost? See your real risk before it happens.
Sem cartão, sem compromisso. Descubra em minutos o que já vazou da sua empresa e qual é o seu risco real.
Building the secure SDLC: security that does not slow the product
The ultimate goal is not to keep finding flaws forever — it is to build a development cycle in which the flaw never reaches production. That is the secure SDLC (Secure Software Development Lifecycle), and in a healthtech it needs to be light enough not to slow the team and rigorous enough to protect clinical data. Decripte helps embed automated controls in the pipeline, so that security becomes a property of the pipeline, not a human bottleneck.
Controls that go into the pipeline
- ✓SAST (static analysis) to catch insecure patterns in the code on every commit.
- ✓SCA to block dependencies with known vulnerabilities before merge.
- ✓Secret scanning to prevent keys and tokens from entering the repository.
- ✓DAST in a staging environment to test the running application.
- ✓Automated authorization tests: cases that attempt the forbidden cross-account access.
- ✓IaC review and cloud configuration policy as code.
- ✓A security gate in CI that fails the build on a critical finding.
The piece that returns the most value is the automated authorization test. Since BOLA escapes functional QA, the defense is to turn 'user A cannot see user B's object' into a test case that runs on every deploy. When the pipeline catches the authorization regression, the customer never sees it. Decripte helps design these cases from the pentest findings, closing the loop between offensive testing and automated prevention.
Shift-left with guardrails
Moving security to the start of development (shift-left) only works if the controls are automatic and low-friction. The goal is for the developer to receive security feedback in the pull request — within seconds, inside the tool they already use — and not in a quarterly audit meeting. Security that gets in the way is security that will be bypassed.
Compliance: LGPD, ANPD, and what the regulator expects
For a healthtech, compliance is not bureaucracy separate from engineering — it is the legal translation of the same technical controls. The LGPD treats health data as sensitive personal data, which requires a specific legal basis for each processing operation (consent, health protection by health professionals or services, or another hypothesis in art. 11), minimization (collecting and exposing only what is necessary), and adequate technical and administrative security measures — exactly the encryption, access control, and auditing that the pentest and the SOC address.
Incident response duty under the LGPD
In the event of a security incident that may pose relevant risk or harm to data subjects, the controller must notify the ANPD and the data subjects within a reasonable timeframe. To comply with this, you need to know, with precision, what leaked, when, from how many data subjects, and what was done — which only exists if there is telemetry, an audit trail, and a tested response plan. Compliance and technical detection capability are the same muscle.
Beyond the LGPD, healthtechs frequently need to respond to contractual requirements from health plans and hospitals that ask for evidence of maturity — security questionnaires, due diligence, and sometimes certifications. ISO/IEC 27001 structures an information security management system and often unlocks enterprise contracts. Those who process card payments also fall within the scope of PCI DSS. Decripte helps map which requirements apply and build auditable evidence — policies, controls, records — without turning the startup into a paperwork machine.
Compliance pillars for healthtech
- ✓Data mapping of processing operations and definition of the legal basis by purpose.
- ✓Minimization and masking of sensitive data in logs, screens, and API responses.
- ✓Retention and secure disposal policy for clinical data.
- ✓Incident response plan with a notification flow to the ANPD and to data subjects.
- ✓Vendor and processor management (clauses, third-party due diligence).
- ✓Record of processing operations and impact report (DPIA) when applicable.
Where to start: from assessment to a continuous program
The worst decision is to wait for the incident to act. The second worst is to try to do everything at once and stall the product. The path that works for a healthtech is sequenced: start with visibility (what exists, what is exposed), attack the risk that matters most (authorization and clinical data), and only then institutionalize via SDLC, SOC, and compliance. Decripte offers a free Threat Management assessment at decripte.com.br/intelligence-center to provide the first snapshot of exposure at no cost or commitment.
Free plan as a starting point
The free Threat Management plan (decripte.com.br/intelligence-center) reveals your healthtech's real exposure based on external intelligence — before any contract. It is the fastest way to turn 'I think we're secure' into concrete data on what an attacker can already see. From there, the progression to pentest, SOC, and compliance is self-service at decripte.io/start.
For most healthtechs, the highest-return combination is: an initial pentest focused on authorization to find what is already exposed, continuous vulnerability management to keep the remediation cadence, a 24x7 SOC to detect abuse in production, and LGPD compliance to turn everything into a defensible process before regulators and enterprise customers. You do not need to buy everything at once — you need to start with the right risk. Talk to Decripte at decripte.io/contato.
Anatomy of a real case: the authorization flaw that exposed patient histories across users
Real, de-identified example
A de-identified real example, without identifying the client. A rapidly growing telemedicine healthtech, with a mobile app and a REST API, had just closed a contract with a health plan and doubled its user base in one quarter. The lean engineering team prioritized shipping. Authorization was checked case by case in the controllers, without a central layer. A clinical history endpoint — GET /api/v1/pacientes/{id}/prontuario — authenticated the user but did not verify whether that patient owned that {id}. The scenario below shows how Decripte would act from discovery to SDLC reconstruction.
Discovery (pentest)
During an application and API pentest contracted by the healthtech, the Decripte team created two test users and, from account A, changed the patient identifier in account B's request. The API returned the other patient's complete record — diagnoses, exams, prescriptions. A classic BOLA (OWASP API #1), reproducible and critical. The proof of concept was documented and the healthtech was alerted immediately, outside the formal report, because it involved sensitive data exposure.
Detection of exploitation
With the protocol triggered, the 24x7 SOC reviewed the logs retroactively to look for actual exploitation prior to the discovery. The object-access telemetry made it possible to identify whether any pattern of sequential ID enumeration had occurred in production — separating the theoretical vulnerability from an actual incident, a decisive distinction for the LGPD notification duty.
Containment (≤1h)
Within the containment SLA of up to 1 hour, Decripte worked with engineering to apply an ownership check on the server — matching the requested {id} against the authenticated subject — blocking cross-account access. In parallel, WAF rules began flagging sequential enumeration of identifiers while the definitive fix was being validated.
Eradication
The point fix was not enough: the same pattern could exist in other endpoints. Decripte ran a targeted sweep of the entire API for analogous authorization breaks (BOLA and BFLA) and helped consolidate the authorization logic into a central, testable layer, eliminating the ad hoc checks scattered across the controllers.
Recovery
Once the fix was validated across all paths via retest, the application was normalized. The audit trail of record access was reinforced to ensure future visibility. Leadership received the impact assessment: what was exposed, for how long, and whether there was actual improper access — input for the decision on notifying the ANPD and the data subjects.
LGPD compliance
Based on the assessment, Decripte supported the healthtech in evaluating the notification duty under the LGPD and in documenting the incident and the measures taken — evidence of diligence that protects the company before the regulator and enterprise customers.
Lessons and secure SDLC
The root cause — the absence of an authorization test in the development cycle — was addressed at the source. Decripte helped embed automated cross-account access tests, SCA, secret scanning, and a security gate in CI into the pipeline, turning the flaw that escaped functional QA into a test case that runs on every deploy.
Outcome with Decripte
In this de-identified real example, the healthtech comes out with the critical flaw eradicated across the entire API, a central and testable authorization layer, clinical data access telemetry, an incident response process documented for the LGPD, and an SDLC that prevents the regression. What began as a BOLA capable of exposing patient histories across users turns into a security program that keeps pace with the product's velocity — continuous pentesting, 24x7 SOC, vulnerability management, and compliance working together. It is exactly this arc, from discovery to automated prevention, that Decripte delivers.
Don’t wait for the incident. Start hardening healthtechs today.
Comece pelo diagnóstico gratuito agora e veja em minutos o que já vazou. SOC 24x7 e contenção em até 1h nos planos pagos.
How Decripte responds to an incident in a healthtech
Decripte's incident response for healthtechs operates with a containment SLA of up to 1 hour and is guided by the sensitive nature of clinical data — each step already accounts for the LGPD's duty of evidence and notification. The flow below applies to a leak via API, authorization abuse, a compromised credential, or cloud exposure.
- Triage and classification: confirm the incident, determine whether there is access to sensitive data, and classify severity by the impact on data subjects — not just by the technique.
- Immediate containment (≤1h): cut the access path (endpoint blocking, credential/token revocation, WAF rule, cloud resource isolation) to stop the leak without destroying evidence.
- Forensic preservation: collect and preserve application, API, authentication, and cloud logs before they rotate, maintaining chain of custody for the investigation and for the LGPD.
- Scope investigation: reconstruct what was accessed, by whom, when, and from how many data subjects — distinguishing an exposed vulnerability from actual exploitation.
- Eradication: fix the root cause and sweep for analogous paths (other endpoints with the same authorization flaw, other leaked secrets, other open configurations).
- Recovery and retest: restore normal operation and validate, with a new test, that the fix actually closed the path across all variations.
- Notification and compliance: support the evaluation of the duty to notify the ANPD and the data subjects and document the incident and the measures — evidence of diligence.
- Lessons learned: convert the incident into a permanent control in the SDLC and in monitoring, so that the same class of flaw does not return.
How Decripte structures a healthtech's security
The structuring is layered and continuous, designed to protect clinical data without slowing the product. The pillars cover the full cycle: find the flaw, detect the abuse, prevent the regression, and prove compliance.
Continuous offensive testing
Application, API, and mobile pentesting focused on broken authorization (BOLA/BFLA), authentication, data exposure, and business logic abuse, with retests integrated into the release cadence — not an annual snapshot.
24x7 detection and response
SOC monitoring behavior (ID enumeration, anomalous exports, unlikely accesses) over clinical data access telemetry, with incident response under a containment SLA of up to 1 hour.
Vulnerability management
Continuous inventory of assets, APIs, and dependencies, prioritization by real exposure of sensitive data, and remediation tracked through to closure with a retest — separating scanner noise from what actually exposes patients.
Automated secure SDLC
SAST, SCA, secret scanning, DAST, and automated authorization tests embedded in the pipeline, with a security gate in CI, so the pipeline catches the regression and the customer never sees it.
Compliance and governance
LGPD compliance (legal basis, minimization, response plan with notification to the ANPD), and support for ISO 27001 and PCI DSS when applicable, turning technical controls into auditable evidence that unlocks enterprise contracts.
Cloud and supply chain security
Configuration hardening, IaC review, secrets management, and cloud posture (CSPM), plus a dependency inventory (SBOM) and validation of third-party integrations treated as untrusted by default.
Recommended plans for Healthtechs
Pentest
Finds the authorization flaw (BOLA/BFLA) that exposes patient records across users before the attacker does, with a reproducible proof of concept and a focus on the healthcare product's business logic — the test that functional QA does not do.
See plan →24x7 SOC
Detects abuse in production that does not trigger an error — ID enumeration, anomalous exports, out-of-pattern record access — over the clinical data access telemetry that the LGPD requires you to know how to monitor.
See plan →Vulnerability Management
Keeps the growing startup's remediation cadence, prioritizing by real exposure of sensitive data and separating the handful of critical flaws from the thousands of scanner alerts, with a retest through to closure.
See plan →Compliance
Translates the technical controls into LGPD compliance for health data (legal basis, minimization, incident response with notification to the ANPD) and into auditable evidence for the due diligence of health plans and hospitals.
See plan →Frequently asked questions
My healthtech is still small. Do I already need to worry about security?
Yes, and precisely because it is small and growing fast. The risk is not proportional to the size of the company, but to the sensitivity of the data — and clinical data is the most sensitive there is. The most severe flaws (broken authorization, leaked secrets, misconfigured cloud) arise exactly in the phase of rapid growth with a lean team. Starting early, even with the free assessment at decripte.com.br/intelligence-center, is far cheaper than responding to a leak.
What is BOLA and why is it so dangerous in healthcare apps?
BOLA (Broken Object Level Authorization) is the number one flaw in the OWASP API Security Top 10. It occurs when the API authenticates who makes the request but does not verify whether that user is entitled to the specific object requested. In healthcare, this means a patient can access another patient's record just by changing a number in the request. It is dangerous because it escapes functional testing (the feature 'works' for the legitimate user) and exposes permanent, irreversible data.
How do I comply with the LGPD when handling health data?
Health data is sensitive personal data under the LGPD, which requires a specific legal basis (art. 11), minimization, adequate technical and administrative security measures (encryption, access control, auditing), and an incident response plan with notification to the ANPD and to data subjects when there is relevant risk or harm. In practice, compliance and technical detection capability are the same muscle: you can only notify correctly if you have telemetry and an audit trail. Decripte structures both.
Does pentesting slow down my product development?
No, when well integrated. Decripte works with continuous pentesting and retests aligned to the release cadence, and helps embed automated security tests in the pipeline. The goal is for the pipeline to catch the authorization regression in seconds in the pull request, not for a quarterly audit to become a bottleneck. Security that gets in the way is security that gets bypassed — that is why the focus is low friction.
What is the difference between the free plan and hiring Decripte?
The free Threat Management plan (decripte.com.br/intelligence-center) gives a snapshot of your healthtech's external exposure based on threat intelligence, at no cost. It is the starting point for understanding the real risk. Hiring (decripte.io/start) adds the active capabilities — pentesting of your application and API, a 24x7 SOC monitoring production, vulnerability management, and LGPD compliance — that actually protect clinical data continuously.
How do I detect whether someone has already accessed records improperly?
Authorization abuse rarely generates an error: the request is technically valid, it just accesses the wrong object. Detecting it requires object-access telemetry (who read which record) and behavioral monitoring — sequential ID enumeration, access spikes by one account, anomalous exports. That is exactly what Decripte's 24x7 SOC does. Without this telemetry, a leak via BOLA can go unnoticed for months, which also compromises LGPD compliance.
Are my integrations with labs and health plans a risk?
Yes — every integration is a trust relationship that can be abused. Supply chain risk includes vulnerable open source dependencies, malicious packages, and third-party APIs consumed without validation. The defense is to treat every partner and every dependency as untrusted by default: SCA in the pipeline, a dependency inventory (SBOM), rigorous input/output validation on each integration, and SSRF review on the endpoints that call external services.
Do I need ISO 27001 or PCI DSS certification?
It depends on what your business requires. ISO/IEC 27001 structures a security management system and frequently unlocks enterprise contracts with hospitals and health plans, which ask for evidence of maturity in due diligence. PCI DSS applies to those who process card payments. The LGPD applies to everyone who handles personal data in Brazil. Decripte helps map which requirements actually apply to your case and build the evidence without turning the startup into a paperwork machine.
Sector terms
- BOLA / IDOR
- Broken Object Level Authorization (also called Insecure Direct Object Reference): a flaw in which the application authenticates the user but does not verify whether they are entitled to the specific object requested. It is the number one item in the OWASP API Security Top 10 and the main cause of patient records leaking across users.
- BFLA
- Broken Function Level Authorization: a flaw in which an ordinary-profile user accesses an administrative function or route that should be restricted to an elevated role — for example, bulk patient export or prescription modification.
- Sensitive personal data
- An LGPD category (art. 5, II) that includes data relating to health. It requires a specific legal basis, a heightened duty of care, and reinforced security measures; its leak is a notification event to the ANPD when there is relevant risk or harm.
- Secure SDLC
- Secure Software Development Lifecycle: a development cycle with security controls embedded in the pipeline (SAST, SCA, secret scanning, DAST, authorization tests, and a CI gate), so that the flaw is blocked in the pipeline before reaching production.
- Supply chain
- Software supply chain: the set of open source dependencies, libraries, and third-party integrations the application relies on. Each link is a trust relationship that can be abused; the defense includes SCA, SBOM, and integration validation.
- CSPM
- Cloud Security Posture Management: continuous monitoring of cloud configuration to detect exposures such as public buckets, internet-accessible datastores, and IAM roles with excessive permissions — the main cause of mass data exposure in the cloud.
Decripte protects and responds to incidents in healthtechs.
Pentest, 24x7 SOC, incident response with a 1-hour containment SLA and compliance — without building an internal team. Or start free by seeing what has already leaked from your company.
